179 related articles for article (PubMed ID: 21128203)
1. The known immunologically active components of Astragalus account for only a small proportion of the immunological adjuvant activity when combined with conjugate vaccines.
Hong F; Xiao W; Ragupathi G; Lau CB; Leung PC; Yeung KS; George C; Cassileth B; Kennelly E; Livingston PO
Planta Med; 2011 May; 77(8):817-24. PubMed ID: 21128203
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of widely consumed botanicals as immunological adjuvants.
Ragupathi G; Yeung KS; Leung PC; Lee M; Lau CB; Vickers A; Hood C; Deng G; Cheung NK; Cassileth B; Livingston P
Vaccine; 2008 Sep; 26(37):4860-5. PubMed ID: 18640165
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines.
Kim SK; Ragupathi G; Musselli C; Choi SJ; Park YS; Livingston PO
Vaccine; 1999 Nov; 18(7-8):597-603. PubMed ID: 10547417
[TBL] [Abstract][Full Text] [Related]
4. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
Ragupathi G; Koide F; Sathyan N; Kagan E; Spassova M; Bornmann W; Gregor P; Reis CA; Clausen H; Danishefsky SJ; Livingston PO
Cancer Immunol Immunother; 2003 Oct; 52(10):608-16. PubMed ID: 12811527
[TBL] [Abstract][Full Text] [Related]
5. Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.
Kim SK; Ragupathi G; Cappello S; Kagan E; Livingston PO
Vaccine; 2000 Oct; 19(4-5):530-7. PubMed ID: 11027818
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.
Zhang J; Wu C; Gao L; Du G; Qin X
Adv Pharmacol; 2020; 87():89-112. PubMed ID: 32089240
[TBL] [Abstract][Full Text] [Related]
7. Effects of triterpene saponins from Astragalus species on in vitro cytokine release.
Yesilada E; Bedir E; Caliş I; Takaishi Y; Ohmoto Y
J Ethnopharmacol; 2005 Jan; 96(1-2):71-7. PubMed ID: 15588652
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity.
Wan CP; Gao LX; Hou LF; Yang XQ; He PL; Yang YF; Tang W; Yue JM; Li J; Zuo JP
Acta Pharmacol Sin; 2013 Apr; 34(4):522-30. PubMed ID: 23524573
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines.
Ragupathi G; Cappello S; Yi SS; Canter D; Spassova M; Bornmann WG; Danishefsky SJ; Livingston PO
Vaccine; 2002 Jan; 20(7-8):1030-8. PubMed ID: 11803062
[TBL] [Abstract][Full Text] [Related]
10. Cycloartane and oleanane saponins from egyptian astragalus spp. as modulators of lymphocyte proliferation.
Verotta L; Guerrini M; El-Sebakhy NA; Assad AM; Toaima SM; Radwan MM; Luo YD; Pezzuto JM
Planta Med; 2002 Nov; 68(11):986-94. PubMed ID: 12451488
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant effects of Astragalus saponins macrophyllosaponin B and astragaloside VII.
Nalbantsoy A; Nesil T; Erden S; Calış I; Bedir E
J Ethnopharmacol; 2011 Apr; 134(3):897-903. PubMed ID: 21296141
[TBL] [Abstract][Full Text] [Related]
12. Astragalus Saponins and Liposome Constitute an Efficacious Adjuvant Formulation for Cancer Vaccines.
Zhang XP; Li YD; Luo LL; Liu YQ; Li Y; Guo C; Li ZD; Xie XR; Song HX; Yang LP; Sun SB; An FY
Cancer Biother Radiopharm; 2018 Feb; 33(1):25-31. PubMed ID: 29466034
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine.
Ragupathi G; Damani P; Srivastava G; Srivastava O; Sucheck SJ; Ichikawa Y; Livingston PO
Cancer Immunol Immunother; 2009 Sep; 58(9):1397-405. PubMed ID: 19190907
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins.
Ragupathi G; Damani P; Deng K; Adams MM; Hang J; George C; Livingston PO; Gin DY
Vaccine; 2010 Jun; 28(26):4260-7. PubMed ID: 20450868
[TBL] [Abstract][Full Text] [Related]
15. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.
Ragupathi G; Meyers M; Adluri S; Howard L; Musselli C; Livingston PO
Int J Cancer; 2000 Mar; 85(5):659-66. PubMed ID: 10699946
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis and Pharmacological Activities of Flavonoids, Triterpene Saponins and Polysaccharides Derived from
Dong M; Li J; Yang D; Li M; Wei J
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446680
[No Abstract] [Full Text] [Related]
17. A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21.
Slovin SF; Ragupathi G; Fernandez C; Jefferson MP; Diani M; Wilton AS; Powell S; Spassova M; Reis C; Clausen H; Danishefsky S; Livingston P; Scher HI
Vaccine; 2005 May; 23(24):3114-22. PubMed ID: 15837210
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation.
Qiu LH; Xie XJ; Zhang BQ
Biol Pharm Bull; 2010; 33(4):641-6. PubMed ID: 20410599
[TBL] [Abstract][Full Text] [Related]
19. Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
Rönnberg B; Fekadu M; Behboudi S; Kenne L; Morein B
Vaccine; 1997 Dec; 15(17-18):1820-6. PubMed ID: 9413088
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological effects of Astragaloside IV: a literature review.
Ren S; Zhang H; Mu Y; Sun M; Liu P
J Tradit Chin Med; 2013 Jun; 33(3):413-6. PubMed ID: 24024343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
